📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease. (2023)

First Author: Dold C

Attributed to: A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.ade3901

PubMed Identifier: 37343082

Publication URI: http://europepmc.org/abstract/MED/37343082

Type: Journal Article/Review

Volume: 15

Parent Publication: Science translational medicine

Issue: 701

ISSN: 1946-6234